THIRD HARMONIC BIO, INC.

Analyst Reco. Third Harmonic Bio, Inc.

Equities

THRD

US88427A1079

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-20 EDT			5-day change	1st Jan Change
14.4 ^USD	+3.86%		+19.40%	+31.27%

05-20	Third Harmonic Bio Insider Sold Shares Worth $331,066, According to a Recent SEC Filing	MT
05-15	Third Harmonic Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts Price Target on Third Harmonic Bio to $7 From $5, Maintains Equalweight Rating	23-08-11	MT
LifeSci Capital Downgrades Third Harmonic Bio to Market Perform From Outperform	22-12-16	MT
Morgan Stanley Downgrades Third Harmonic Bio to Equalweight From Overweight, Slashes Price Target to $5 From $34	22-12-16	MT
Jefferies Downgrades Third Harmonic Bio to Hold From Buy, Slashes Price Target to $3.60 From $30	22-12-16	MT
Jefferies & Co Initiates Coverage on Third Harmonic Bio With Buy Rating, $30 Price Target	22-10-10	MT
Morgan Stanley Starts Third Harmonic Bio at Overweight With $34 Price Target	22-10-10	MT
Cowen Starts Third Harmonic Bio at Outperform	22-10-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW